Vyvanse is not marketed as an appetite suppressant, but appetite loss is one of its most common side effects. In user-reported data, about 13% of people taking Vyvanse experience a noticeable decrease in appetite. This effect is significant enough that the FDA has approved Vyvanse for treating moderate to severe binge eating disorder in adults, though it is not approved for weight loss itself.
Why Vyvanse Reduces Appetite
Vyvanse (lisdexamfetamine) is a stimulant medication primarily prescribed for ADHD in adults and children ages 6 and older. Like other stimulants, it increases levels of dopamine and norepinephrine in the brain. These chemical changes sharpen focus and attention, but they also dial down hunger signals. The brain’s reward system, which partly controls the desire to eat, becomes less responsive to food cues while the drug is active.
This isn’t a targeted appetite-suppression mechanism. It’s a side effect of how stimulants work on the central nervous system. That’s an important distinction: dedicated weight loss drugs like phentermine are specifically classified as “anorexiants,” meaning their primary purpose is to reduce appetite. Vyvanse is classified only as a CNS stimulant, and appetite suppression happens as a byproduct of its main effects.
How Long the Effect Lasts Each Day
Vyvanse is a prodrug, meaning your body has to convert it into its active form before it starts working. This process takes roughly 90 minutes to two hours after you swallow the capsule. So if you take it at 7:00 in the morning, the effects typically kick in around 9:00 a.m.
From there, Vyvanse is one of the longest-lasting stimulant medications available, staying active for 10 to 14 hours. That means appetite suppression can persist well into the evening, often until 8:00 or 9:00 p.m. for someone who took their dose in the morning. This creates a common pattern: minimal hunger throughout the day, followed by a rebound of intense hunger once the medication wears off at night. Many children and adults on Vyvanse find themselves suddenly starving in the late evening, which is when they tend to make up for missed calories.
Vyvanse for Binge Eating Disorder
In 2015, the FDA approved Vyvanse as the first medication specifically indicated for moderate to severe binge eating disorder in adults. To qualify as moderate to severe, a person generally needs to have at least three binge episodes per week. The approval was based on clinical trials showing that Vyvanse reduced the number of binge eating days per week compared to a placebo.
This approval does not extend to general weight loss or obesity treatment. The FDA label explicitly notes that Vyvanse is not intended for weight management. In clinical practice, doctors prescribe it for BED because it reduces the compulsive urge to binge, not simply because it suppresses hunger. The distinction matters: binge eating disorder involves a loss of control around food that goes beyond normal appetite, and Vyvanse appears to address the impulsive behavior driving the binges, not just the desire to eat.
How It Compares to Weight Loss Medications
Phentermine, one of the most commonly prescribed weight loss drugs, is specifically designed to curb appetite. Yet in user-reported side effect data, only about 3% of phentermine users flagged appetite loss as a notable side effect, compared to about 13% of Vyvanse users. That comparison is somewhat misleading, though. Phentermine users expect appetite reduction as the whole point of the drug, so they may be less likely to report it as a “side effect.” Vyvanse users, who are typically taking it for ADHD or binge eating, are more likely to notice and report the appetite change as something unexpected.
The practical difference is that phentermine is approved for short-term use (typically a few weeks) in people with a BMI of 30 or higher, or 27 or higher with conditions like high blood pressure or diabetes. Vyvanse can be taken long-term for ADHD or BED. Prescribing Vyvanse purely for appetite suppression or weight loss is considered off-label, and most doctors will not do so given its stimulant classification and potential for dependence.
Managing Appetite Loss on Vyvanse
If you’re taking Vyvanse for ADHD or BED and struggling with too little appetite, timing your meals around the medication’s activity window can help. Eating a solid breakfast before the drug takes effect (within that first 90-minute window) gives you a chance to get calories in before hunger disappears. Many people also find that calorie-dense snacks like nuts, cheese, or smoothies are easier to get down than full meals during the day, since they require less appetite to consume.
The late-evening rebound hunger is worth planning for as well. Having a substantial, nutritious meal ready for when the medication wears off can help you avoid going to bed with a calorie deficit. For children on Vyvanse, this evening catch-up window is especially important for growth. Some pediatricians monitor weight and height regularly to make sure kids on the medication are still gaining appropriately.
Unintended weight loss that continues over weeks or months is worth discussing with your prescriber. Adjusting the dose, changing the timing, or switching medications are all options if appetite suppression becomes a problem rather than a manageable side effect.